Objective: This study aims to investigate the role of paraoxonase 1 activity and Q192R polymorphism in the development of nephropathy in patients with Type 2 diabetes mellitus.
Introduction
Diabetes mellitus, the most common disease, accounted for around 350 million cases in 2014 (1) . The prevalence of diabetes was estimated to be about 8% worldwide in 2011 and was predicted to increase up to 10% by 2030 (2) . The chronic complications diabetes include damage, dysfunction and/or failure of various organs especially the retina, kidneys, nerves, heart, and vessels (3) . Severe complications of diabetes such as retinopathy, neuropathy, nephropathy and cardiovascular complications are the results of either tissue or vascular damage (4) . DN is a microvascular complication of diabetes. This kidney disease develops in 20-40% of the patients with diabetes (5) . The risk factors for the development of DN include hyperglycemia, hypertension, dyslipidemia, smoking and a family history of DN (6) . Hyperglycemia occurs first, leading to the development of different pathological events which cause the overt proteinuria, ultimately resulting in glomerulosclerosis and End Stage Renal Disease (7) . It is largely found in circulation in forms bound to HDL. The protective effects of HDL are predominantly due to PON1 (8) . PON1 hydrolyzes the phospholipids and hydroperoxides to oxidized LDL and also destroys the proinflammatory molecules involved in the initiation and progression of microvascular complications in diabetes (9) . PON1 helps in maintaining the functions of HDL by preventing its oxidation, preserves the antiatherogenic functions of HDL, and reduces the oxidation of LDL (10) . Q and R alleles of polymorphism at position 192 combine to give three phenotypes: QQ, QR, and RR. The Q192R polymorphism markedly influences the enzyme activity for different substrates (11) . 192RR individuals show the highest paraoxonase activity, while 192QQ individuals demonstrate a higher lactonase activity (12) . Although several studies have demonstrated the relationship between PON1, Q192R polymorphism, and coronary artery disease; yet,other studies focusing on Q192R site could not identify the polymorphism an independent risk factor (13, 14) . The literature reports many studies correlating paraoxonase polymorphism in DM patients. S. Araki et al. observed that there was no association between the PON1 polymorphism and DN (15), while Gokcen et al. observed a significant association between the PON1 polymorphism and DM (16) . As different studies present conflicting results there is a need for further research to study the effect of DN on serum PON1 status. The present study was designed to investigate whether the PON1 arylesterase activity and its Q192R polymorphism are associated with DN in a group of patients with T2DM, besides other risk factors.
Material and Methods
One hundred patients, having diabetes for more than five years, admitted to SRTR Govt. Medical College and Hospital were randomly selected. The patients having DN were compared with those without nephropathy. Age and sexmatched controls were selected from the diabetics who did not have any complication and attended the regular medical check-up in the hospital. Nephropathy was determined by calculating Urinary Albumin/Creatinine Ratio (UACR). UACR<30 mg/gm: normoalbuminuria (mg of albumin and gm of creatinine) UACR=30-300 mg/gm: microalbuminuria (mg of albumin and gm of creatinine) UACR >300 mg/gm: macroalbuminuria (mg of albumin and gm of creatinine). Patients with UACR >30 mg/gm were selected. The protocol for this study was approved by the institutional ethics committee of the Medical College. Written informed consent was obtained from all the patients. The patients with associated ischemic heart disease, rheumatoid arthritis, concomitant liver, kidney diseases other than DN, a history of exogenous hormone administration and those having DM for a period of less than five yearswere excluded from the study. Allthe patients included in the study were questioned in detail regarding the disease history.
Biochemical Analysis
All the fine chemicals were obtained from Sigma-Aldrich, Mumbai, Maharashtra, India Venous blood samples were collected aseptically from all patients in the morning, after an overnight fast. Random samples of urine from the same patients were also obtained and were subjected to estimation of urinary albumin and creatinine usingpyro- Mogarekar et 22:151-157 gallol red method (17) and Jaffe's alkaline picrate method (18) , respectively. The serum was separated by low-speed centrifugation and was subjected to various biochemical analyses. Random blood samples collected in fluoride bulb were analyzed within a few hours for the estimation of plasma glucose using glucose oxidaseperoxidase method (19) .
Measurement of PON1 arylesterase activity
Phenylacetate was used as a substrate for determining the arylesterase activity. The rate of hydrolysis was measured spectrophotometrically, using the assay mixture which contained 4.0 mM/L phenylacetate and 1 mM/L CaCl 2 in 20 mM/L Tris HCl buffer at a pH 8.0 and temperature 25°C (20) . The rate of phenol formation was recorded at 270 nm following 20 s lag time. The activity was expressed as kU/L, based on the extinction coefficient of phenol, which was noted to be 1310 M -1 cm -1 at 270 nm, pH 8.0 and 25°C. Intra assay coefficient of variation (CVs) was 3.2%.
PON1 polymorphism
Each study subject was phenotyped for the PON1 Q192R polymorphism by using the dual substrate method. The ratio of inhibited to the non-inhibited activity which represents the ratio of phenylacetate inhibited arylesterase activity (IA) with p-nitro phenyl acetate as a substrateto non-inhibited arylesterase activity (NIA) with p-nitrophenyl acetate alone as a substrate, was taken into consideration. The rate of formation of p-nitrophenol was determined at 405 nm at a temperature of 25 ºC over 225 s, following 100 slag time. The activity was expressed in kU/L, based on the molar absorptivity (14000 M -1 cm -1 min -1 ) of p-nitrophenol at 405 nm and a pH 7.4 (21).
Lipid profile in diabetic nephropathy
The levels of total cholesterol, HDL cholesterol and triglycerides were measured using enzymatic techniques; LDL cholesterol was calculated using the Friedewald formula (22) .
Statistical Analysis
The esults presented as mean±standard deviation. The continuous variables were tested for normality using Shapiro-Wilk test.
The statistical analysis for the numerical variables in Gaussian distributionwas carried out using Student's unpaired t-test. The number of individuals with each phenotype was compared using the chi-square test. The deviation of observed allele frequency, from those predicted by Hardy-Weinberg equilibrium, was evaluated by the chisquare test. The univariate and multivariate logistic regression analyses were used for assessing the risk of DN, as contributed by various risk factors. The results were analyzed using the Mystat-12 statistical software. The significance level was assigned to be <0.05.
Results
One hundred patients having diabetes for more than five years and admitted to the SRTR Govt. Medical College and Hospital were selected for the study (50 patients with DN and, 50 type 2 diabetic patients without nephropathy were selected as controls). The mean age of the individuals included in the study was 56±10.48 and 58.82±9.33 years in the control and patient group, respectively. While no significant difference in age and sex between the patients and controls was observed, Student's t-test showed that parameters like duration of diabetes, Random BSL, total cholesterol and LDL-C cholesterol were significantly higher in the patient group as compared to the controls. There was no significant difference in TG, VLDL-C, and HDL-C among the patients and controls. PON1 arylesterase activity was found to be significantly lower in subjects as compared to that in the controls ( Table 1) . The phenotypic distribution of PON1 polymorphism (QQ, QR, and RR phenotypes) was not significantly distinct between the patients and controls (Table 2 ). PON1 arylesterase activity showed a significant difference in terms of QQ, QR and RR phenotypes between the patients and controls (Table 3 ). In the univariate logistic regression, considering DN as a dependent factor, all parameters except serum triglyceride, HDL-C, and VLDL-Showed a significant contribution to the risk of nephropathy in diabetic patients ( Table 4 ). The significant parameters univariate regression were modeled through multivariate regression ands-R and PON1 Table 3 . Distribution of PON1 arylesterase activity according to phenotype.
arylesterase activity showed an independent, significant contribution in the nephropathy in diabetes along with other parameters; however, in combination with other known parameters, RR phenotype lost its significance as observed in the multiple logistic regression (Table 5) .
Discussion
Genetic predisposition, quality of glycemiccontrol, duration of diabetes, level of blood pressure, and smoking are some of the known risk factors for DN (23) . Besides these, the role of other factors in the development of DN was also seen in the study. evidently found in thestudy that the duration of diabetes in thepatients was significantly higher than that in the controls ( (24) . In the present study, PON1 arylesterase activity in the patient group (85.4 ±24.12 kU/L) was observed to be significantly lower than that in the control group (127.94±25.51 kU/L) (p<0.001). Univariate logistic regression considerably indicated it to bea protective factor in the development of DN, showing an odds ratio of 1.073 and Neglekerke's R 2 value of 0.565 (p<0.01). Multivariate logistic regression, which was also in combination with other variables, showed that PON1 arylesterase activity contributed significantly to the development of nephropathy in diabetes. LI C et al. (2009) (25) and El-said N. H. et al. (2015) (26) also found that patients with nephropathy had a lower PON1 activity as compared to their controls, which is in line with the present study. In DN, PON1 glycation causes dissociation of PON1 from HDL, making PON1 less stable; glycation also impairs the reverse cholesterol transport ability of HDL, all of which may cause a decrease in PON1 activity as evident in this study, which was confirmed by Rosenblat M et al. (27) and Hedrick CC et al. (28) . Tabur S. et al. (29) explained that DN is a state of oxidative stress, in which PON1 arylesterase activity is decreased; an antioxidant enzyme has been reported to be associated with an increase in the reactive oxygen radicals and oxidative stress. In the present study, phenotype-wise distribution of PON1 Q192R polymorphism showed no significant difference between the patients and controls. RR homozygotes were observed to be independently associated with the development of DN in the univariate logistic regression; however, in the multivariate logistic regression, it lost its significance. Q192 provides protection against microangiopathic, probably due to the effective hydrolysis of hydroperoxides and peroxides of PON1 QQ, as established by Murata M et al. (2004) (30) in their study. Hampe M et al. (2014) , in a crosssectional study, investigated the role of paraoxonase 1 (PON1) status such as activity and Q192R polymorphism in the development of Diabetic Retinopathy (DR) in patients with type 2 DM, and found that retinopathy was significantly associated with PON1 R allele carriers in diabetic patients
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The dependent factor is the presence or absence of disease (Cases are taken as reference). LDL= Low Density Lipoprotein; BSL-R = Random blood sugar level; DM: Diabetes mellitus. (33) . The reasons for these discrepancies may be the differences in the type of diabetes, ethnicity, and other genetic contributors. More extensive and preferably prospective studies are required to confirm the results of the present study. The main limitation of this study is the small sample size, which is not enough to establish the predictive value of PON-1 polymorphism in DN. PON1 genotyping, which is more definitive, has not been performed in the present study. Thus, a false classification of few individuals, among the three phenotypes, could have been possible. Further, the actual concentration of PON1 has not been directly calculated in the present study and a larger cohort study is therefore required to serve this purpose.
Conclusion
The authors ultimately conclude according to the results of the present study that the PON1 arylesterase activity in diabetic patients with nephropathy is reduced as compared to that in the diabetic patients without nephropathy, due to an increase in the oxidative stress and PON1 glycation in DN. Diabetic patients having R allele are susceptible to the development of nephropathy in the course of diabetes, thus,PON1 status is an additional risk factor for the development of nephropathy along with the known risk factors already prevailing.
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